FindTrial
Sign In

Treatment to Bicuspid Aortic Valve Related Aortopathy

Treatment to Bicuspid Aortic Valve Related Aortopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039867
Enrollment
Unknown
Registered
2020-11-12
Start date
2020-11-01
Completion date
Unknown
Last updated
2021-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bicuspid Aortic Valve related Aortopathy

Interventions

Aortic valve replacement group:Nil
Bentall group:Nil
Aortic Ascending Replacement group:Nil

Sponsors

Beijing Anzhen Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Bicuspid Aortic Valve with significant aortic dysfunction, including aortic valve replacement, aortic valve replacement combined ascending aortic replacement , Bentall ,or with commitment CABG, AFA.

Exclusion criteria

Exclusion criteria: Patients with aortic valve repair, aortic repair, thoracic replacement or mitral replacement are excluded.

Design outcomes

Primary

MeasureTime frame
Death;—

Secondary

MeasureTime frame
Bleeding;—

Countries

China

Contacts

Public ContactSun Lizhong

Beijing Anzhen Hospital

lizhongsun@foxmail.com+86 13811270124

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026